Activation of TLR2 in mammary epithelial stem cells and in breast cancer cells enhances the expression of stemness-related genes, promoting the acquisition of CSC properties that contribute to treatment resistance and tumor recurrence [39]. Here, TLR2 is linked to breast carcinoma.